Stay updated on Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2 on the Study Details page. No study data, eligibility criteria, outcomes, or locations appear to be affected.SummaryDifference0.1%

- Check21 days agoChange DetectedMinor site revision update from v3.2.0 to v3.3.1; no changes to study content or essential page details were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding and operating status notice has been removed from the page.SummaryDifference0.4%

- Check43 days agoChange DetectedNo significant changes were observed in the page content; only minor non-substantive UI tweaks were seen. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded a government-funding notice and updated to version v3.2.0; removed reference to v3.1.0.SummaryDifference3%

- Check79 days agoChange DetectedAdded multiple new phone numbers and updated the revision to v3.1.0; removed the old revision tag v3.0.2.SummaryDifference0.1%

Stay in the know with updates to Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.